The NVIDIA-Powered AI Drug Discovery Ecosystem Across the globe, innovators are building the future of AI for drug discovery ...

In addition, Der Simulierte Mensch (Si-M), The Simulated Human, a new research center, is being finalized in Berlin to open in 2026. Neubauer explains this is a joint partnership between TU Berlin and ...

Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...

How AI, robotics, and modular design are transforming single-cell and spatial biology into scalable, precision-driven engines of discovery.

NVIDIA (NVDA) on Monday said it is expanding its BioNeMo platform for AI-driven biology and drug discovery, unveiling new software models, data tools and partnerships aimed at linking artificial ...

Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, today announced it has raised $8 million USD Seed investment. The oversubscribed round was led by Initialized ...

Today, the majority of cell biology operations are carried out manually, even though the core steps are highly reproducible. Staff are expected to conduct repetitive tasks for hours each day, and ...

The world's largest and most successful trade fair for Laboratory Technology, Analysis and Biotechnology, analytica takes ...

Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, today announced it has raised $8 million USD Seed investment. The oversubscribed round was led by Initialized ...

San Francisco, 06 May 2025: Trilobio, which is building an automated robotic lab-in-a-box for biologists, today announced it has raised $8 million USD Seed investment. The oversubscribed round was led ...